Wednesday, May 13, 2026

COVID-19 therapy

December 2, 2021

Omicron: GlaxoSmithKline announces UK-approved drug for new variant

The pharmaceutical company on Thursday said that further tests will be carried out on the Sotrovimab therapy to firm up the results.

GlaxoSmithKline